US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sionna Therapeutics

12.69

+0.66005.49%

Volume:205.13K

Turnover:2.49M

Market Cap:559.94M

PE:-0.79

High:12.86

Open:12.16

Low:11.67

Close:12.03

Loading ...

Overview Company News Filings

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?

BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing

Orbimed Advisors Llc Reports 8.4% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing

THOMSON REUTERS

Major Stock Acquisition Signals Confidence in Sionna Therapeutics

Major Stakeholders Make Bold Moves on Sionna Therapeutics Stock!

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Opening Day: Sionna Therapeutics, Titan America make public debut

BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debut

Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand

BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO

Sionna Therapeutics Upsized IPO Priced at High End of Views

Sionna Therapeutics Prices $191 million IPO

MT Newswires Live

BRIEF-Sionna Therapeutics Prices Upsized IPO Of 10.6 Mln Shares At $18/Share

Sionna Therapeutics Inc - Prices Upsized IPO of 10.6 Mln Shares at $18/Share

THOMSON REUTERS

Sionna Therapeutics Prices Upsized Initial Public Offering

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SION/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SION","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","market":"US","secType":"STK","nameCN":"Sionna Therapeutics","latestPrice":12.69,"timestamp":1746125807355,"preClose":12.03,"halted":0,"volume":205134,"delay":0,"floatShares":15943083,"shares":44124394,"eps":-15.986072,"marketStatus":"Trading","change":0.66,"latestTime":"05-01 14:56:59 EDT","open":12.16,"high":12.86,"low":11.67,"amount":2494205.228538,"amplitude":0.098919,"askPrice":12.87,"askSize":108,"bidPrice":12.68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-15.986072,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"listingDate":1738904400000,"exchange":"NASDAQ","adjPreClose":12.03,"preHourTrading":{"tag":"盘前","latestPrice":12.13,"preClose":12.03,"latestTime":"09:29 EDT","volume":451,"amount":5369.3011240000005,"timestamp":1746106198408},"postHourTrading":{"tag":"盘后","latestPrice":12.03,"preClose":12.03,"latestTime":"16:00 EDT","volume":304,"amount":3657.12,"timestamp":1746043227083},"volumeRatio":2.586508},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"SION\",,,,,undefined,":{"symbol":"SION","floatShares":15943083,"roa":"-37.10%","roe":"-61.44%","lyrEps":-15.986072,"volumeRatio":2.586508,"shares":44124394,"dividePrice":0,"high":12.86,"amplitude":0.098919,"preClose":12.03,"low":11.67,"week52Low":7.255,"pbRate":"-3.42","week52High":25.19,"institutionHeld":0,"latestPrice":12.69,"committee":-0.038462,"eps":-15.986072,"divideRate":0,"volume":205134,"delay":0,"ttmEps":-15.986072,"open":12.16,"prevYearClose":18,"prevWeekClose":12.14,"prevMonthClose":12.03,"prevQuarterClose":10.46,"fiveDayClose":12.6,"twentyDayClose":11.83,"sixtyDayClose":18},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SION\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512762839","title":"Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2512762839","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512762839?lang=en_us&edition=fundamental","pubTime":"2025-02-18 05:43","pubTimestamp":1739828634,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Insiders Are Buying This Year. In this article, we are going to take a look at where Sionna Therapeutics, Inc.  stands against other stocks that insiders are buying this year.Even though this is just the beginning of the year, we thought it might be interesting to see what stocks have attracted the most attention from insiders. Why?Sometimes, when executives or insiders acquire shares early in the year, it could mean that they expect strong financial results or positive company developments.On the other hand, insiders sometimes sell shares at the beginning of the year for tax reasons. For example, they can sell shares to harvest tax loss or to balance out gains/losses from the previous year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sionna-therapeutics-sion-among-stocks-214354896.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NVIW.SI","BK4585","NQmain","USJW.SI","BK4139","USAW.SI","CF",".IXIC","BK4093","SQQQ","QID","TSYW.SI","SION","BK4588","QLD","PSQ","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2511813505","title":"BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511813505","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511813505?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:13","pubTimestamp":1739484801,"startTime":"0","endTime":"0","summary":"BRIEF-Orbimed Advisors Llc Reports 8.4% Stake In Sionna Therapeutics As Of Feb 10 - SEC FilingSionna Therapeutics Inc SION.O:ORBIMED ADVISORS LLC REPORTS 8.4% STAKE IN SIONNA THERAPEUTICS AS OF FEB 10 - SEC FILINGSource text: [ID:]Further company coverage: SION.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41ZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2511850378","title":"Orbimed Advisors Llc Reports 8.4% Stake in Sionna Therapeutics as of Feb 10 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2511850378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511850378?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:12","pubTimestamp":1739484765,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nFWN3P41ZC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION"],"gpt_icon":0},{"id":"2511084554","title":"Major Stock Acquisition Signals Confidence in Sionna Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2511084554","media":"TIPRANKS","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511084554?lang=en_us&edition=fundamental","pubTime":"2025-02-13 10:07","pubTimestamp":1739412465,"startTime":"0","endTime":"0","summary":"New insider activity at Sionna Therapeutics, Inc. ( ($SION) ) has taken place on February 13, 2025. Former 10% Owner TPG GP A, LLC has made a signi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stock-acquisition-signals-confidence-in-sionna-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stock-acquisition-signals-confidence-in-sionna-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2510884164","title":"Major Stakeholders Make Bold Moves on Sionna Therapeutics Stock!","url":"https://stock-news.laohu8.com/highlight/detail?id=2510884164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510884164?lang=en_us&edition=fundamental","pubTime":"2025-02-11 10:05","pubTimestamp":1739239510,"startTime":"0","endTime":"0","summary":"New insider activity at Sionna Therapeutics, Inc. ( ($SION) ) has taken place on February 11, 2025. In a series of significant transactions, Direct...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stakeholders-make-bold-moves-on-sionna-therapeutics-stock?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stakeholders-make-bold-moves-on-sionna-therapeutics-stock?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SION"],"gpt_icon":0},{"id":"2510890162","title":"Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2510890162","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510890162?lang=en_us&edition=fundamental","pubTime":"2025-02-11 05:03","pubTimestamp":1739221380,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  10, 2025  (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/10/3023780/0/en/Sionna-Therapeutics-Announces-Closing-of-219-2-million-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0034235188.USD","LU0106831901.USD","IE0004086264.USD","IE0002270589.USD","BK4127","LU1668664300.SGD","IE0004091025.USD","BK4552","LU2237443382.USD","BK4093","SION","BK4585","BK4533","IE00BFXG1179.USD","BK4550","BK4504","LU2237443622.USD","LU1791807156.HKD","LU2237443549.SGD","IE00B19Z3B42.SGD","LU2237443895.HKD","CF","LU2237443465.HKD","USA","IE00BSNM7G36.USD","LU2237438978.USD","LU2237443978.SGD","BK4516","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2509773778","title":"Opening Day: Sionna Therapeutics, Titan America make public debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2509773778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509773778?lang=en_us&edition=fundamental","pubTime":"2025-02-08 03:55","pubTimestamp":1738958112,"startTime":"0","endTime":"0","summary":"Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a modest...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/opening-day-sionna-therapeutics-titan-america-make-public-debut?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/opening-day-sionna-therapeutics-titan-america-make-public-debut?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TTAM","SION"],"gpt_icon":0},{"id":"2509221227","title":"BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2509221227","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509221227?lang=en_us&edition=fundamental","pubTime":"2025-02-08 02:15","pubTimestamp":1738952126,"startTime":"0","endTime":"0","summary":"BUZZ-Sionna Therapeutics jumps nearly 40% in cracking Nasdaq debutUpdates** Shares of drug developer Sionna Therapeutics SION.O jump as much as 38.9% in their Nasdaq debut; last up 38.1% at $24.86** Stock opened for trading at $25 vs $18 IPO price, giving it a market capitalization of $1.06 billion** SION sold ~10.6 million shares, 20% more than initially offered, at the top end of its marketed range of $16 to $18 apiece to raise $190.6 million** Founded in 2019 and previously known as Sling Therapeutics, SION is developing drugs to treat cystic fibrosis** SION is vying for a slice of the cystic fibrosis market that is dominated by drugmaker Vertex Pharmaceuticals VRTX.O ** Vertex booked almost $10 billion in sales in 2023 and has significantly impacted cystic fibrosis treatment** SION is evaluating its experimental drug candidates SION-719 and SION-451 in early-stage trials in Australia** Prior to the IPO, SION had raised about $330 million from investors, including RA Capital and TPG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL4N3OY1LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","SF","LU0889565916.HKD","LU2237438978.USD","BK4552","LU0061475181.USD","IE0034235188.USD","BK4585","LU1585245621.USD","LU2236285917.USD","IE0004086264.USD","LU2237443465.HKD","LU2417539215.USD","SION","IE00BZ9MQY76.HKD","IE00B2B36J28.USD","BK4127","LU0079474960.USD","LU2456880835.USD","LU1035775433.USD","LU0417517546.SGD","BK4516","BK4588","BK4532","LU1093756168.USD","LU0256863811.USD","LU2362541273.HKD","LU2237443978.SGD","LU2362540622.SGD","LU0109394709.USD","LU2462157665.USD","IE0002141913.USD","IE00B19Z3581.USD","BK4504","LU0058720904.USD","LU1668664300.SGD","VRTX","IE0002270589.USD","LU2324357040.USD","LU1069344957.HKD","IE00B19Z9Z06.USD","LU1791807156.HKD","IE00BSNM7G36.USD","IE0009355771.USD","LU0289739699.SGD","IE00B894F039.SGD","BK4139","IE00BFXG1179.USD","LU0320765992.SGD","LU0234570918.USD"],"gpt_icon":0},{"id":"1121625472","title":"Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=1121625472","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121625472?lang=en_us&edition=fundamental","pubTime":"2025-02-08 02:02","pubTimestamp":1738951353,"startTime":"0","endTime":"0","summary":"Shares of Sionna Therapeutics  surged 38.89% in its trading debut on Friday, buoyed by investor enthusiasm for the clinical-stage biopharmaceutical company's successful initial public offering .Sionna, which is developing drugs to treat cystic fibrosis, sold 10.6 million shares at $18 per share in its upsized IPO, raising $191 million. The IPO was priced at the top end of its expected range, reflecting strong investor demand for the company's shares.Based in Waltham, Massachusetts, Sionna is vyi","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | Sionna Therapeutics Soars 38.89% on IPO Debut, Fueled by Strong Investor Demand","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["SION"],"gpt_icon":0},{"id":"2509533728","title":"BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2509533728","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509533728?lang=en_us&edition=fundamental","pubTime":"2025-02-07 23:46","pubTimestamp":1738943213,"startTime":"0","endTime":"0","summary":"BUZZ-Sionna Therapeutics set to open 33% above offer price after upsized $191 mln IPO** Shares of drug developer Sionna Therapeutics SION.O set to open 33% above their offer price in their Nasdaq debut. ** Stock indicated to open at $24 vs $18 IPO price. ** SION sold ~10.6 mln shares, 20% more than initially offered, at the top end of its marketed range of $16 to $18 apiece to raise $190.6 mln** At the IPO price, the Waltham, Massachusetts-based firm fetched a valuation of $765.4 mln ** Founded in 2019 and previously known as Sling Therapeutics, SION is developing drugs to treat cystic fibrosis** SION is vying for a slice of the cystic fibrosis market that is dominated by drugmaker Vertex Pharmaceuticals VRTX.O ** Vertex booked almost $10 billion in sales in 2023 and has significantly impacted cystic fibrosis treatment** Prior to the IPO, SION had raised about $330 mln from investors, including RA Capital, TPG's The Rise Fund, Atlas Venture, OrbiMed and Enavate Sciences** Goldman Sachs","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL4N3OY1FV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0106831901.USD","IE0004086264.USD","LU1430594728.SGD","IE0002270589.USD","LU1668664300.SGD","LU1035775433.USD","IE0004091025.USD","BK4552","LU2237443382.USD","LU1069344957.HKD","LU2362540622.SGD","LU1585245621.USD","IE00B894F039.SGD","IE00B2B36J28.USD","SION","LU0320765992.SGD","BK4139","LU2456880835.USD","BK4585","BK4533","LU2462157665.USD","IE00BFXG1179.USD","BK4550","LU0061475181.USD","BK4504","VRTX","LU2237443622.USD","BK4567","LU1791807156.HKD","IE00B19Z3B42.SGD","LU2237443895.HKD","IE00BJJMRZ35.SGD","LU0417517546.SGD","LU2237443465.HKD","IE00B4R5TH58.HKD","IE00B19Z9P08.USD","LU0889565916.HKD","LU0079474960.USD","SF","IE00BSNM7G36.USD","LU0289739699.SGD","LU0234570918.USD","LU2237438978.USD","LU2237443978.SGD","LU0109394709.USD","LU2362541273.HKD","IE00BJT1NW94.SGD","BK4516","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2509118567","title":"Sionna Therapeutics Upsized IPO Priced at High End of Views","url":"https://stock-news.laohu8.com/highlight/detail?id=2509118567","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509118567?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:18","pubTimestamp":1738927080,"startTime":"0","endTime":"0","summary":"Shares of Sionna Therapeutics are set to be traded Friday after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the top end of expectations.Sionna late Thursday said it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares at between $16 and $18 each.The Waltham, Mass., company said it expects gross proceeds of about $191 million.Sionna shares are slated to begin trading Friday on the Nasdaq Global Market under the symbol SION.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2509912657","title":"Sionna Therapeutics Prices $191 million IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2509912657","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509912657?lang=en_us&edition=fundamental","pubTime":"2025-02-07 16:46","pubTimestamp":1738918019,"startTime":"0","endTime":"0","summary":"Sionna Therapeutics  said late Thursday it has priced an initial public offering of about 10.6 million shares at $18 per share for expected gross proceeds of $191 million.The cystic fibrosis-focused pharmaceutical firm said its shares are scheduled to begin Nasdaq trading Friday under the ticker symbol \"SION.\"Sionna has also granted underwriters a 30-day option to purchase up to about 1.6 million additional shares.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SION"],"gpt_icon":0},{"id":"2509734991","title":"BRIEF-Sionna Therapeutics Prices Upsized IPO Of 10.6 Mln Shares At $18/Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2509734991","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509734991?lang=en_us&edition=fundamental","pubTime":"2025-02-07 08:53","pubTimestamp":1738889603,"startTime":"0","endTime":"0","summary":"BRIEF-Sionna Therapeutics Prices Upsized IPO Of 10.6 Mln Shares At $18/ShareFeb 6 (Reuters) - Sionna Therapeutics Inc SION.O:SIONNA THERAPEUTICS PRICES UPSIZED INITIAL PUBLIC OFFERINGSIONNA THERAPEUTI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nTUA9NCKZ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SION"],"gpt_icon":0},{"id":"2509734967","title":"Sionna Therapeutics Inc - Prices Upsized IPO of 10.6 Mln Shares at $18/Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2509734967","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509734967?lang=en_us&edition=fundamental","pubTime":"2025-02-07 08:51","pubTimestamp":1738889470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nTUA9NCKZ7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SION"],"gpt_icon":0},{"id":"2509737628","title":"Sionna Therapeutics Prices Upsized Initial Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2509737628","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509737628?lang=en_us&edition=fundamental","pubTime":"2025-02-07 08:51","pubTimestamp":1738889460,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  06, 2025  (GLOBE NEWSWIRE) -- Sionna Therapeutics Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/07/3022521/0/en/Sionna-Therapeutics-Prices-Upsized-Initial-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFXG1179.USD","LU1668664300.SGD","IE0034235188.USD","SION","IE00B19Z3B42.SGD","BK4552","IE0004086264.USD","LU0106831901.USD","IE0002270589.USD","BK4127","CF","LU1791807156.HKD","IE00B19Z3581.USD","IE0004091025.USD","BK4533","BK4093","BK4550","BK4504","LU2237443895.HKD","USA","BK4516","LU2237443382.USD","LU2237438978.USD","IE00BSNM7G36.USD","LU2237443465.HKD","LU2237443549.SGD","LU2237443622.USD","LU2237443978.SGD","BK4585","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SION\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SION\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SION\",market:\"US\",delay:true,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1741320000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SION\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:true,algorithm:1,,,undefined,":{"brief":{"id":"SION","date":"2025-04-30","current":-8.61201,"percent":0.631579,"low":-18.418073,"twenty":-13.187073,"median":-10.565632,"eighty":-7.983992,"high":-5.47907,"avg":-10.575689,"sd":3.084788,"marketCap":531257703},"quantilePoints":[{"date":"2025-02-07","current":-13.261013,"twenty":-12.252025,"median":-10.738543,"eighty":-9.22506,"marketCap":765372600},{"date":"2025-02-14","current":-14.940741,"twenty":-16.115077,"median":-14.940741,"eighty":-13.535074,"marketCap":862319796},{"date":"2025-02-21","current":-15.365065,"twenty":-15.365065,"median":-14.763927,"eighty":-14.631317,"marketCap":886810118},{"date":"2025-02-28","current":-11.280197,"twenty":-15.101402,"median":-14.760244,"eighty":-13.045594,"marketCap":651047865},{"date":"2025-03-07","current":-11.960372,"twenty":-15.059369,"median":-14.631317,"eighty":-11.310767,"marketCap":690304817},{"date":"2025-03-14","current":-13.068521,"twenty":-15.036515,"median":-13.072343,"eighty":-11.387191,"marketCap":754262771},{"date":"2025-03-21","current":-10.607665,"twenty":-14.940741,"median":-12.594692,"eighty":-11.280197,"marketCap":612232003},{"date":"2025-03-28","current":-8.569094,"twenty":-14.763927,"median":-12.189644,"eighty":-10.607665,"marketCap":528610240},{"date":"2025-04-04","current":-8.304439,"twenty":-14.75656,"median":-11.44833,"eighty":-8.654927,"marketCap":512284214},{"date":"2025-04-11","current":-5.47907,"twenty":-14.719724,"median":-11.345158,"eighty":-8.304439,"marketCap":337992858},{"date":"2025-04-17","current":-7.152833,"twenty":-14.648998,"median":-11.146455,"eighty":-7.438946,"marketCap":441243940},{"date":"2025-04-25","current":-9.012569,"twenty":-13.535074,"median":-10.607665,"eighty":-7.830921,"marketCap":555967364},{"date":"2025-04-30","current":-8.61201,"twenty":-13.187073,"median":-10.565632,"eighty":-7.983992,"marketCap":531257703}],"updateTime":1746088300684}}}